Klotho vs NAD+
A side-by-side research comparison of Klotho and NAD+ across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Klotho | NAD+ |
|---|---|---|
| Full name | Klotho Protein | Nicotinamide Adenine Dinucleotide (NAD+ / NMN / NR) |
| Category | Anti-Aging | Anti-Aging |
| Status | Research compound (preclinical/early) | Research compound |
| Mechanism | Exists in membrane-bound and soluble forms. Soluble Klotho acts as a circulating hormone that modulates FGF23 signaling, regulates phosphate/vitamin D balance, suppresses certain growth and oxidative-stress pathways, and supports synaptic and cognitive function. | NAD+ serves as cofactor for sirtuins (SIRT1-7), PARPs (DNA repair), and CD38. Declining NAD+ impairs mitochondrial function and epigenetic maintenance. Restoration reactivates longevity pathways. |
| Molecular weight | ~130 kDa (full protein; fragments studied) | 663.4 Da |
| Half-life | Not well established for therapeutic forms | 1-4 hours (IV), 4-8h (oral precursors) |
| Bioavailability | Injectable in research; large protein with limited oral absorption | 100% (IV), variable (oral 5-30%) |
| Typical dose | No established human dose | 250-500mg IV or 500-1000mg NMN oral |
| Frequency | Unknown | Weekly (IV) or Daily (oral) |
| Route | Injection (research) | IV infusion or Oral (precursors) |
Klotho reported benefits
- Associated with longevity and slower aging
- Neuroprotection and improved cognition (preclinical)
- Supports kidney and cardiovascular health
- Regulates phosphate and mineral balance
NAD+ reported benefits
- Restored cellular energy
- Enhanced DNA repair
- Sirtuin activation
- Improved mitochondrial function
- Cognitive clarity
- Anti-aging
Related comparisons
Research and educational reference only. Not medical advice.